Diseases (AASLD) also presented and continued to revise their clinical practice guidelines,
and the latest updates were in 2015, 2017, and 2018. However, since the medical …

Aims The Korean Association for the Study of the Liver (KASL) Practice Guidelines for
Management of Hepatitis C were first established in 2004, and revised in 2013, when direct …

In the setting of intensive immunosuppression for the management of rejection in solid organ
transplant (SOT) recipients, or graft-versus-host disease (GVHD) in hematopoietic stem cell …

BACKGROUND & AIMS: We investigated the efficacy of entecavir, a cyclopentyl guanosine
nucleoside analogue, as monoprophylaxis in patients with chronic hepatitis B who received …

Abstract Wait‐listed (n= 226) or post–liver transplantation (n= 241) chronic hepatitis B (CHB)
patients with lamivudine‐resistant hepatitis B virus (HBV) were treated with adefovir dipivoxil …

Background Prophylaxis of HBV recurrence is critical after liver transplantation in HBV
patients. Despite new prophylactic schemes, most European LT centres persist on a …

The combination of hepatitis B immunoglobulin (HBIG) and nucleos (t) ide analogues [NA
(s)] is considered as the standard of care for prophylaxis against HBV recurrence after liver …

Long‐term immunoprophylaxis with hepatitis B immune globulin (HBIG) is widely accepted
for the prevention of recurrent hepatitis B virus (HBV) infection after liver transplantation in …

Many diseases that cause liver failure may recur after transplantation. A retrospective
analysis of the rate and cause of graft loss of 1840 consecutive adults receiving a primary …

Atotal of 5 to 10% of patients undergoing ortho-topic liver transplantation (OLT) have
hepatitis B virus (HBV)–associated chronic or fulminant liver disease. Long-term survival …